Coronary Artery Bypass Graft Market (2023-2030): Industry Insights, SWOT Analysis, Market Size, Share, and Key Growth Factors | KARL STORZ GmbH & Co. KG MAQUET Holding B.V. & Co.KG NeoGraftTechnologies.Inc

Coronary artery bypass graft market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2024-2031).Coronary artery bypass graft surgery (CABG) is done to treat a blockage or narrowing of 1 or more of the coronary arteries. It can restore the blood supply to heart muscle when nonsurgical procedures are not a choice.

Get Free Sample link @ https://www.omrglobal.com/request-sample/coronary-artery-bypass-graft-market

The market is growing due to increased myocardial infarction, an increasing geriatric population, and a favorable reimbursement scenario. According to the national library of Medicine estimate, myocardial infarction accounts for 3 million lives globally. In addition, as per the estimates of the United Nations, the geriatric population is expected to double by 2.1 billion in 2050. The geriatric population is more prone to cardiovascular diseases as fat deposits build up over the wall of arteries over a period of time. Moreover, a favorable reimbursement scenario is also positively influencing the market growth.

full report of Coronary Artery Bypass Graft Market available @ https://www.omrglobal.com/industry-reports/coronary-artery-bypass-graft-market

• Market Coverage
• Market number available for - 2024-2031
• Base year- 2024
• Forecast period- 2024-2031
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
• Inc., and others

Market Segmentation
Global Coronary Artery Bypass Graft Market by Technology
o Off-pump CABG
o On-pump CABG
o Minimally Invasive Direct

Global Coronary Artery Bypass Graft Market by Surgical Procedure
o Single CABG Surgery
o Double CABG Surgery
o Triple CABG Surgery
o Quadruple CABG Surgery

Global Coronary Artery Bypass GraftMarket by End Users
o Hospitals
o Cardiology Clinics

Regional Analysis
o North America
o United States
o Canada
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
o Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
o Rest of the World
o Latin America
o Middle East & Africa

Company Profiles
o Boston Scientific Corp.
o Edwards Lifesciences Corp.
o Genesee Biomedical Inc.
o Guidant Group
o KARL STORZ GmbH & Co. KG
o MAQUET Holding B.V. & Co.KG
o NeoGraftTechnologies.Inc
o Novadaq Technologies Inc.
o Scanlan International
o Sorin Group
o Stryker Corp.
o Teleflex Inc.

The Report Covers
• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global coronary artery bypass graftmarket. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/coronary-artery-bypass-graft-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

This release was published on openPR.